General
Preferred name
OLMESARTAN MEDOXOMIL
Synonyms
OLMESARTAN ()
CS 866 ()
CS-866,RNH-6270 ()
Olmesartan medoxomilo ()
Olmetec ()
Olmesartan medoxomil component of benicar hct ()
Benicar ()
NSC-758924 ()
CS-866 ()
Olmesartan medoxomil component of tribenzor ()
Olmesartan medoxomil component of azor ()
Olmesartan Medoxomil-d6 ()
P&D ID
PD000567
CAS
144689-63-4
1127298-67-2
Tags
available
prodrug
drug
Approved by
FDA
First approval
2002
Drug indication
Hypertension
High blood pressure
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 ¦ÌM.
DESCRIPTION
Selective non-peptide AT1 antagonist; prodrug of Olmesartan
(Tocriscreen Plus)
DESCRIPTION
Olmesartan is an angiotensin receptor blocker (ARB) used in the treatment of hypertension.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
26
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocriscreen Plus
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
44
Molecular Weight
558.22
Hydrogen Bond Acceptors
11
Hydrogen Bond Donors
2
Rotatable Bonds
10
Ring Count
5
Aromatic Ring Count
5
cLogP
4.17
TPSA
162.16
Fraction CSP3
0.31
Chiral centers
0.0
Largest ring
6.0
QED
0.24
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
MOA
angiotensin receptor antagonist
Target
Type-1 angiotensin II receptor
AGTR1
Angiotensin Receptor
Indication
hypertension
Therapeutic Class
Antihypertensive Agents
Pathway
GPCR/G protein
Source data

